Clinical Trial

Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.

Completed
View on ClinicalTrials.gov →
Summary
This study evaluated the preemptive analgesic efficacy of Tapentadol in reducing peri operative analgesic requirements among patients undergoing breast cancer surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-21.
Trial Details
NCT Number NCT07320781
Lead Sponsor Shaukat Khanum Memorial Cancer Hospital & Research Centre
Conditions Breast Cancer
Enrollment 70 participants
Start Date 2024-11-15
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-10-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-08